Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis: A Phase I/II Multicenter, Randomized, Double-Blinded Safety Study

Administered By

Medicine, Rheumatology and Immunology

Awarded By

Benaroya Research Institute at Virginia Mason

Contributors

Shah, Ankoor Principal Investigator

Start/End

February 1, 2018 - January 31, 2020